But seriously, folks, now that the Trial is over, Congress will turn its attention to the Stimulus Bill and pass it by the end of February with the Covid Rapid Testing funds.
Hopefully by that time the FDA will have approved Innova's tests. (not politics, policy)
---
One company working on rapid tests, Innova Medical Group, says it could be making millions of its tests available to the United States right now if the FDA would grant authorization. Instead, the company is making tests in a California plant and shipping them overseas.
“So California, actually, in an interesting way, is a net exporter of tests that the United States isn't using, because of the challenges with the FDA,” Daniel Elliott, the company’s CEO, said in an interview.
“If the U.S. government today said, ‘OK, go,’ I could deliver 60 million tests before the end of February,” Elliott said.
The California facilities will be able to make 5 million tests per day by the end of February, the company says.
The company first applied to the FDA in August, Elliott said, and has been facing a series of questions from the agency for months.
https://thehill.com/policy/healthcare/538349-...d-19-tests
Hopefully by that time the FDA will have approved Innova's tests. (not politics, policy)
---
One company working on rapid tests, Innova Medical Group, says it could be making millions of its tests available to the United States right now if the FDA would grant authorization. Instead, the company is making tests in a California plant and shipping them overseas.
“So California, actually, in an interesting way, is a net exporter of tests that the United States isn't using, because of the challenges with the FDA,” Daniel Elliott, the company’s CEO, said in an interview.
“If the U.S. government today said, ‘OK, go,’ I could deliver 60 million tests before the end of February,” Elliott said.
The California facilities will be able to make 5 million tests per day by the end of February, the company says.
The company first applied to the FDA in August, Elliott said, and has been facing a series of questions from the agency for months.
https://thehill.com/policy/healthcare/538349-...d-19-tests
